A single cohort study shows an increased risk for esophageal cancer in patients taking long-term proton-pump inhibitor (PPI) therapy, but experts are skeptical about the finding.
Medscape Medical News
Original Article: Long-term PPI Use and Increased Esophageal CA Risk